Last reviewed · How we verify

NCT06693102

Digital Intervention Targeting Cancer-related Cognitive Impairments

Not yet recruiting NA Last updated 18 November 2024
What this trial tests

NA trial testing Digital intervention targeting cancer-related cognitive impairments in Cancer in 60 participants. Not yet recruiting.

Timeline
2 January 2025
Primary endpoint
2 January 2028
2 January 2028

Quick facts

Lead sponsorHaukeland University Hospital
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date2 January 2025
Primary completion2 January 2028
Estimated completion2 January 2028
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

Haukeland University Hospital

Who can join

Adults 18 to 65, any sex, with Cancer or Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cognitive deficits are frequently reported following cancer treatment and can significantly impact daily functioning. These cognitive impairments often persist for years after cancer treatment. This study aimed to examine several aspects of a newly developed digital intervention designed to address cognitive impairments. Specifically, it focused on: (1) evaluating the preliminary effects of the intervention, (2) identifying predictors of treatment response, (3) assessing the feasibility of both the intervention and the study design, (4) gathering participant feedback on the intervention, and (5) testing the applicability of the Norwegian version of the Working Memory Questionnaire within this patient group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other Haukeland University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06693102.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing